The Role of Matrix Metalloproteinases in Colorectal Cancer
AbstractIn the United States, colorectal cancer (CRC) is the third leading cause of cancer mortality, with limited treatment options for those with advanced disease. Matrix metalloproteinases (MMPs) are important for maintaining extracellular homeostasis but also play a prominent role in cancer cell invasion and dissemination. Expression levels of MMP-1, -2, -7, -9 and -13 correlate with worse outcomes; MMP-12 expression appears to be protective. Hence, MMPs are attractive therapeutic targets. Previous clinical trials using broad-spectrum MMP inhibitors were disappointing because of off-target toxicity and lack of efficacy. Now, the availability of safer, more selective inhibitors has renewed interest in therapeutic targeting of MMPs. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Said, A.H.; Raufman, J.-P.; Xie, G. The Role of Matrix Metalloproteinases in Colorectal Cancer. Cancers 2014, 6, 366-375.
Said AH, Raufman J-P, Xie G. The Role of Matrix Metalloproteinases in Colorectal Cancer. Cancers. 2014; 6(1):366-375.Chicago/Turabian Style
Said, Anan H.; Raufman, Jean-Pierre; Xie, Guofeng. 2014. "The Role of Matrix Metalloproteinases in Colorectal Cancer." Cancers 6, no. 1: 366-375.